An astonishing new benefit of Mounjaro has emerged: the potential to reverse deadly liver disease. Belinda and Gillian, two patients who suffered from fibrosis and cirrhosis, now see signs of recovery. Doctors are praising the drug's effectiveness, but it's not without controversy. The story of these two women highlights the potential of GLP-1 weight-loss drugs to tackle liver disease, a condition that affects up to one in five adults. However, the NHS has yet to approve these drugs for this specific condition, leaving patients like Belinda paying high prices for a potentially life-saving treatment. The article explores the impact of Mounjaro on liver disease, the current state of treatment options, and the ongoing debate surrounding the drug's accessibility and cost.
